Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity

This study has been completed.
Information provided by:
University of Oslo School of Pharmacy Identifier:
First received: July 7, 2005
Last updated: December 2, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2005
  Estimated Primary Completion Date: No date given